Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study.

Zhang, Ying; Ding, Jing Xin; Tao, Xiang; Lu, Zhi Ying; Wang, Jia Jia; Feng, Wei Wei; Hua, Ke Qin

Zhang, Ying; Ding, Jing Xin; Tao, Xiang; Lu, Zhi Ying; Wang, Jia Jia; Feng, Wei Wei; Hua, Ke Qin.

Affiliation

Zhang Y; Department of Gynecology, The Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

J Chemother ; 25(2): 96-103, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23684357

Subject(s)

Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use; Cisplatin/pharmacology; Cisplatin/therapeutic use; Gonadotropin-Releasing Hormone/agonists; Goserelin/pharmacology; Goserelin/therapeutic use; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/pathology; Animals; Antineoplastic Agents/adverse effects; Antineoplastic Agents, Hormonal/pharmacology; Antineoplastic Agents, Hormonal/therapeutic use; Cell Proliferation/drug effects; Cisplatin/adverse effects; Down-Regulation/drug effects; Female; Humans; Mice; Tumor Cells, Cultured

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Gonadotropin-Releasing Hormone / Cisplatin / Goserelin / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2013 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google